federal_register: 2022-08572

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2022-08572 Drug Products, Including Biological Products, That Contain Nanomaterials; Guidance for Industry; Availability Notice The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Drug Products, Including Biological Products, That Contain Nanomaterials." This guidance finalizes the draft guidance issued December 18, 2017, developed to provide industry with the Agency's current thinking for the development of human drug products, including those that are biological products, in which a nanomaterial is present in the finished dosage form. The guidance also includes recommendations for applicants and sponsors of investigational, premarket, and postmarket submissions for these products. 2022-04-22 2022 4 https://www.federalregister.gov/documents/2022/04/22/2022-08572/drug-products-including-biological-products-that-contain-nanomaterials-guidance-for-industry https://www.govinfo.gov/content/pkg/FR-2022-04-22/pdf/2022-08572.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Drug Products, Including Biological Products, That Contain Nanomaterials." This guidance finalizes the draft guidance issued...  

Links from other tables